Six BioManufacturing Trends to Watch in 2022 The COVID-19 pandemic shed a light on the strengths and shortcomings of the global biotech infrastructure in relation to pandemic readiness and general support of biotech innovation. Governments and industry have taken notice and billions of dollars in new funding is being poured into the BioManufacturing sector at […]
Introduction Currently within esports there is a need to develop more holistic wellbeing practices and strategies to support all levels of gamers. With esports continuing to grow in popularity and with more professional and semi-professional teams entering the arena there is a growing responsibility of these teams to look after the wellbeing of their esports […]
In addition to its significant efforts to fast track the approval of COVID-19 related devices, the FDA’s Center for Devices and Radiological Health (CDRH) has also maintained its high priority focus on supporting innovation of new medical devices in the United States.
According to CDRH Director Jeff Shuren, M.D., J.D., the FDA has now granted emergency use authorization (EUA) or full marketing authorization to over 2,000 medical devices intended to prevent, diagnose, or treat COVID-19 and more than half of CDRH’s workforce has been directly involved in the COVID-19 response. CDRH moved quickly with respect to COVID-19 treatment devices to ensure the availability of the wide range of related products shown below, including diagnostic tests, personal protective equipment (PPE), ventilators, and other critical devices and supplies for health care providers and patients.
As one example, CDRH authorized 15 additional over-the-counter (OTC) COVID-19 tests for at-home use during 2021. According to CDRH Director Shuren, these were authorized in record times—in some cases in less than a week—highlighting CDRH’s devotion to providing a rapid response to the COVID-19 pandemic.
Importantly, CDRH’s pandemic-related efforts have not brought its other authorizations to a grinding halt. Instead, CDRH also managed to clear or approve 13 devices with breakthrough designation and granted market authorization for 103 novel devices during 2021. “One way that we are measuring the success of our efforts is through tracking the number of innovative medical technologies being brought to the U.S. first so that patients have access to the safest and most innovative devices available,” says Shuren. “A decade ago, the U.S. was too often behind in this regard. But we are gratified to see our efforts have resulted in 103 novel devices receiving marketing authorization in 2021, despite the unprecedented demands of our pandemic response,” continues Shuren. “Spurring innovation in developing safer, more effective devices is key to improving patient care and quality of life.”
Giving marketing authorization to 103 novel devices is touted by the Annual Report as “an incredible achievement” in light of the increased demand on CDRH staff resulting from the COVID-19 pandemic. “This highlights the commitment and dedication of CDRH staff to strengthen public health by bringing innovative devices to patients,” comments CDRH.
In the past ten years, CDRH has issued four times as many approvals, authorizations, and clearances of novel technologies as a result of the innovative policies and approaches developed and implemented by CDRH. Novel technologies include those brought to market through the Premarket Approval, Humanitarian Device Exemption, and De Novo pathways, as well as a subset of those brought to market through Emergency Use Authorization (EUA), or the Breakthrough Devices Program.
The Breakthrough Devices Program is another important program to emerging companies that provides device manufacturers with an opportunity to engage directly with CDRH’s experts through several different program options to address topics as they arise during device development, evaluation, and premarket review. Some of the benefits of this program are expedited feedback to manufacturers and prioritized submission review. By the numbers, in 2021, CDRH granted breakthrough designation to 213 devices, which is roughly one-third of all designations since the program’s inception in 2015, and granted marketing authorization to 13 breakthrough devices (including 3 Premarket Approvals, 3 510(k)s, and 7 De Novos).
Blockchain.com sponsors leading esports organizationCrypto people and gamers understand the internet economy better than anyone.We get it. We live it.The idea of creators,...
There’s no shortage of t-shirt templates and clothing mockup generators online to help you create great images for your clothing brand. The difficult part is sorting through all the poor quality ones to find the best ones that will work for you and give your brand the quality it deserves. Here’s a list of the best t-shirt templates and mockup generators.
Tiny Tina's Wonderlands, as you’ve already seen in our first hands-on preview, is a mash-up of Borderland's unique shooter-looter setting and the world...
Docker is one of the two most popular DevOps platforms for data scientists. There are over nine million Docker accounts and the number of developers using Docker is growing 30% a year. There are a lot of compelling reasons that Docker is becoming very valuable for data scientists and developers. One of the reasons is […]
Value-building sustainable business practices must start at the top — here’s what enterprise business leaders should be doing to make sustainability part of their culture and operations. Pursuing profit and growth at the exclusion of other considerations is no longer an option for enterprise business leaders who want to be successful. Ignoring corporate social responsibility […]
Ryanair, a budget airline in the United Kingdom (UK) has been voted to be the worst short-haul carrier for processing refunds during the COVID-19 pandemic. The passengers of the airline are not at all satisfied with their experience in dealing […]
